Related Experiment Video
Updated: Jun 14, 2025

08:58
Fully Automated Centrifugal Microfluidic Device for Ultrasensitive Protein Detection from Whole Blood
Published on: April 16, 2016
10.5K
DNA circuit-based immunoassay for ultrasensitive protein pattern classification
Antoine Masurier1, Rémi Sieskind1, Guillaume Gines1
1Gulliver Laboratory, ESPCI Paris Université PSL, 10 rue Vauquelin, 75005 Paris, France. guillaume.gines@espci.fr.
The Analyst
|August 29, 2024
Summary
This study introduces immuno-PUMA (i-PUMA), a novel DNA nanotechnology-based immunoassay for ultrasensitive cytokine detection. This method offers improved sensitivity and molecular computing capabilities for disease diagnostics.
Area of Science:
- Biotechnology
- Nanotechnology
- Immunology
Background:
- Cytokines are crucial immune modulators and biomarkers for disease diagnostics.
- Traditional immunoassays like ELISA detect proteins individually, limiting multiplexed analysis.
- DNA nanotechnology enables sophisticated biomolecular systems for molecular computing and pattern recognition.
Purpose of the Study:
- To develop an ultrasensitive protein detection assay using DNA nanotechnology.
- To couple ELISA convenience with DNA/enzyme circuit computing capabilities.
- To demonstrate the assay's potential for molecular computation and multimarker classification.
Main Methods:
- Development of immuno-PUMA (i-PUMA), an isothermal amplification-based immunoassay.
- Integration of DNA/enzyme circuits with ELISA principles for enhanced detection.
- Application of i-PUMA for detecting Interleukin-12 (IL12), Interleukin-4 (IL4), and Interferon-gamma (IFNγ) cytokines.
Main Results:
- Achieved ultrasensitive detection limits: 2.1 fM for IL12, 8.7 fM for IL4, and 450 aM for IFNγ.
- Demonstrated superior sensitivity compared to traditional ELISA methods.
- Successfully created 2-input perceptron-like classifiers for IL12 and IL4 using i-PUMA's computational abilities.
Conclusions:
- i-PUMA is a sensitive, low-cost, and versatile immunoassay for protein detection.
- The assay complements existing molecular profiling techniques with its molecular computing functions.
- i-PUMA holds significant potential for advanced diagnostics and multimarker-based sample classification.

